Mahmoud ABU-ABEELEH Associate Professor of Surgery Division
... “During the long night, helplessly watching the patient struggle for life as her blood became darker and her veins more distended, the idea naturally occurred to me that if it were possible to remove some of the blue blood…put oxygen into that blood and allow carbon dioxide to escape from it, and th ...
... “During the long night, helplessly watching the patient struggle for life as her blood became darker and her veins more distended, the idea naturally occurred to me that if it were possible to remove some of the blue blood…put oxygen into that blood and allow carbon dioxide to escape from it, and th ...
Cardio-Renal Syndrome.
... increases in severity as the disease progresses1 • Pathological changes in sympathetic nervous activity contribute to the higher incidence of sudden cardiac death in CKD and ESKD patients: • Plasma norepinephrine predicts survival and incident cardiovascular events in patients with ESKD2 – Heart-rat ...
... increases in severity as the disease progresses1 • Pathological changes in sympathetic nervous activity contribute to the higher incidence of sudden cardiac death in CKD and ESKD patients: • Plasma norepinephrine predicts survival and incident cardiovascular events in patients with ESKD2 – Heart-rat ...
The European Society of Cardiology and the Latest Guidelines for
... generation DES, and for 6 (or even 3) months for the new generation everolimus- and zotarolimus-eluting DES. The premature cessation of double antiplatelet treatment exponentially increases the risk of in-stent thrombosis and should be avoided. Every attempt should be made to ensure that the patient ...
... generation DES, and for 6 (or even 3) months for the new generation everolimus- and zotarolimus-eluting DES. The premature cessation of double antiplatelet treatment exponentially increases the risk of in-stent thrombosis and should be avoided. Every attempt should be made to ensure that the patient ...
heart attack
... and interruption of normal blood flow to a part of the brain ___% Obstructive or ischemic ___% Hemorrhagic (____________ ruptures) - aneurysm is a weakening and ballooning of a vessel 750,000 strokes/year (160,000 deaths) ...
... and interruption of normal blood flow to a part of the brain ___% Obstructive or ischemic ___% Hemorrhagic (____________ ruptures) - aneurysm is a weakening and ballooning of a vessel 750,000 strokes/year (160,000 deaths) ...
Heart mate iii anticoagulation
... Background Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new. A left ventricular assist device (LVAD) pumping blood from the left ventricle to the aorta, connected to an externally worn control u ...
... Background Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new. A left ventricular assist device (LVAD) pumping blood from the left ventricle to the aorta, connected to an externally worn control u ...
Prognostic significance of premature ventricular contractions without
... with the multivariate Cox proportional hazards model to calculate the risk (hazard ratio) of the endpoints. 3. Results No PVC morphology (overall, left bundle branch block, right bundle branch block, other) was associated with increased all-cause death or cardiac death. Participants with PVC of left ...
... with the multivariate Cox proportional hazards model to calculate the risk (hazard ratio) of the endpoints. 3. Results No PVC morphology (overall, left bundle branch block, right bundle branch block, other) was associated with increased all-cause death or cardiac death. Participants with PVC of left ...
CRT-D or CRT-P in CRT-indicated patients?
... There was no statistically significant correlation between HRV parameters and 6-minute walking test, functional capacity, right ventricular systolic function, BNP and hs-troponin-I levels. Most common cause of death in these patients is arrhythmia, and autonomic dysfunction may be triggering factor ...
... There was no statistically significant correlation between HRV parameters and 6-minute walking test, functional capacity, right ventricular systolic function, BNP and hs-troponin-I levels. Most common cause of death in these patients is arrhythmia, and autonomic dysfunction may be triggering factor ...
As Powerpoint Slide
... Figure 1. Fibrosis of the aging heart. Cardiac aging is associated with significant alterations in cardiac structure and function. Elderly patients often present with left ventricular hypertrophy and diastolic dysfunction while the systolic function is usually preserved. Age-dependent remodeling of ...
... Figure 1. Fibrosis of the aging heart. Cardiac aging is associated with significant alterations in cardiac structure and function. Elderly patients often present with left ventricular hypertrophy and diastolic dysfunction while the systolic function is usually preserved. Age-dependent remodeling of ...
Heart Disease - Oldham Sixth Form College
... world population is 6.2 billion and growing Last year 60 million people died Circulatory diseases such as coronary heart disease and stroke were the biggest killer, killing 17 million people Yet, at any one time the media tends to concentrate upon one or two ‘fashionable illnesses’. The papers fil ...
... world population is 6.2 billion and growing Last year 60 million people died Circulatory diseases such as coronary heart disease and stroke were the biggest killer, killing 17 million people Yet, at any one time the media tends to concentrate upon one or two ‘fashionable illnesses’. The papers fil ...
Ventricular assist devices - Annals of Cardiothoracic Surgery
... the device, which may disrupt blood flow and lead to a stroke or heart attack. Bleeding may also occur, as in any open-heart surgery and as a result of the blood-thinning medications needed to reduce the risk of blood clots. As the device uses a connection which passes from the body’s exterior, thro ...
... the device, which may disrupt blood flow and lead to a stroke or heart attack. Bleeding may also occur, as in any open-heart surgery and as a result of the blood-thinning medications needed to reduce the risk of blood clots. As the device uses a connection which passes from the body’s exterior, thro ...
10 Abstract from Kas..
... aortic valve surgery is performed. Treatment with β-adrenergic receptor antagonists (β-blockers) is beneficial in patients with heart failure, but the effect of β-blocker therapy in aortic regurgitation is unclear. This trial was designed to evaluate the effect of controlled release metoprolol on le ...
... aortic valve surgery is performed. Treatment with β-adrenergic receptor antagonists (β-blockers) is beneficial in patients with heart failure, but the effect of β-blocker therapy in aortic regurgitation is unclear. This trial was designed to evaluate the effect of controlled release metoprolol on le ...
National Heart Failure Audit: outcomes remain poor, but evidence
... Mortality rates are high both in hospital and following discharge, with 11.6% of patients dying during their admission and over 30% dying within a year of discharge; these figures do not represent an improvement on mortality rates reported in 2009/10. Morbidity rates are also high, and heart failu ...
... Mortality rates are high both in hospital and following discharge, with 11.6% of patients dying during their admission and over 30% dying within a year of discharge; these figures do not represent an improvement on mortality rates reported in 2009/10. Morbidity rates are also high, and heart failu ...
Short‑Term Effects of Ivabradine in Patients with Chronic Stable
... Introduction: Ivabradine is a novel selective If current inhibitor with anti‑ischemic and antianginal activity. Objectives: To assess the effect of the selective If current inhibitor ivabradine on heart rate, angina pectoris, and functional capacity in stable patients with chronic coronary artery di ...
... Introduction: Ivabradine is a novel selective If current inhibitor with anti‑ischemic and antianginal activity. Objectives: To assess the effect of the selective If current inhibitor ivabradine on heart rate, angina pectoris, and functional capacity in stable patients with chronic coronary artery di ...
A Machine Without an Owner`s Manual
... durability of these hemodynamic changes and the potential that ramp testing should be repeated with some frequency must be addressed. ...
... durability of these hemodynamic changes and the potential that ramp testing should be repeated with some frequency must be addressed. ...
Myocardial infarction
... Long-term prognosis after MI - depends on many factors, the most important of which are left ventricular function and the severity of atherosclerotic narrowing of vessels perfusing the remaining viable myocardium. - Mortality rate within the first year =30% • Thereafter, the annual mortality rate i ...
... Long-term prognosis after MI - depends on many factors, the most important of which are left ventricular function and the severity of atherosclerotic narrowing of vessels perfusing the remaining viable myocardium. - Mortality rate within the first year =30% • Thereafter, the annual mortality rate i ...
CHRONIC HEART FAILURE Ivabradine
... Ivabradine (Procoralan®) is a pure heart-rate lowering agent licensed for use in heart failure. Data from the SHIFT study demonstrated that heart rate reduction using ivabradine in selected patients with chronic heart failure can significantly reduce hospitalisations due to worsening heart failure, ...
... Ivabradine (Procoralan®) is a pure heart-rate lowering agent licensed for use in heart failure. Data from the SHIFT study demonstrated that heart rate reduction using ivabradine in selected patients with chronic heart failure can significantly reduce hospitalisations due to worsening heart failure, ...
The achievement of the congress of European Society of Cardiology
... toxicity” reviews the different steps in cardiovascular monitoring and decision-making before, during and after cancer treatment with potential cardiovascular side effects. Although this document is not a formal clinical practice guideline, it aims to assist professionals involved in the treatment o ...
... toxicity” reviews the different steps in cardiovascular monitoring and decision-making before, during and after cancer treatment with potential cardiovascular side effects. Although this document is not a formal clinical practice guideline, it aims to assist professionals involved in the treatment o ...
What is AFib?
... stroke each year will increase significantly the more points you have. There are now many strategies to reduce the risk of stroke. This decision is always individualized, based on one’s risk factors and other conditions that may contraindicate the use of certain drugs. Please refer to separate secti ...
... stroke each year will increase significantly the more points you have. There are now many strategies to reduce the risk of stroke. This decision is always individualized, based on one’s risk factors and other conditions that may contraindicate the use of certain drugs. Please refer to separate secti ...
Heart failure with preserved ejection fraction in rheumatoid arthritis
... heart failure [2], predicts mortality [9,10] and observed decrease in its level correlates with improved diastolic function [2]. Liang et al. have reported that RA patients are at increased risk of developing diastolic dysfunction compared to the normal population. In their study, IL-6 level and dis ...
... heart failure [2], predicts mortality [9,10] and observed decrease in its level correlates with improved diastolic function [2]. Liang et al. have reported that RA patients are at increased risk of developing diastolic dysfunction compared to the normal population. In their study, IL-6 level and dis ...
Is it Form or Function? - JACC: Cardiovascular Interventions
... assigned to optimal medical therapy alone. Although the number of patients in this substudy is modest, the baseline characteristics were quite similar to the overall COURAGE trial. Whereas the treatment assignment did not predict outcomes, the impact of the quantitative anatomic burden “form” and th ...
... assigned to optimal medical therapy alone. Although the number of patients in this substudy is modest, the baseline characteristics were quite similar to the overall COURAGE trial. Whereas the treatment assignment did not predict outcomes, the impact of the quantitative anatomic burden “form” and th ...
Spies: Back in Circulation
... 7. What are the upper chambers of the heart called? 8. What are the lower chamber of the heart called? 9. What is circulation called between the heart and lungs? 10. What is circulation called between the heart and the rest of the body? Not found in reading selection….. 11. Could the circulatory sys ...
... 7. What are the upper chambers of the heart called? 8. What are the lower chamber of the heart called? 9. What is circulation called between the heart and lungs? 10. What is circulation called between the heart and the rest of the body? Not found in reading selection….. 11. Could the circulatory sys ...
Corlentor® receives approval for use in heart
... Chronic heart failure affects 1.2 million patients in Spain (10% of the population over 60 years of age).4 It is a disabling condition and, despite improvements in treatment and management, generally has a poor prognosis, with a survival of only 50% after five years from the diagnosis. In Spain, hea ...
... Chronic heart failure affects 1.2 million patients in Spain (10% of the population over 60 years of age).4 It is a disabling condition and, despite improvements in treatment and management, generally has a poor prognosis, with a survival of only 50% after five years from the diagnosis. In Spain, hea ...
A brief discussion of submassive pulmonary embolism
... suggestive of increased pulmonary pressure. Massive PE is commonly defined as one that does cause hypotension. Note that these definitions do not necessarily relate to the actual size of a PE or total clot burden. It should also be noted that literature can be found using other definitions. These pa ...
... suggestive of increased pulmonary pressure. Massive PE is commonly defined as one that does cause hypotension. Note that these definitions do not necessarily relate to the actual size of a PE or total clot burden. It should also be noted that literature can be found using other definitions. These pa ...